at proteina diamond plus columns (PROTEINA Co Ltd)
90
Structured Review
PROTEINA Co Ltd
at proteina diamond plus columns
At Proteina Diamond Plus Columns, supplied by PROTEINA Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/at+proteina+diamond+plus+columns/at+proteina+diamond+plus+columns/10__1016_slash_j__bej__2024__109428-79-10-10
Average 90 stars, based on 1 article reviews
At Proteina Diamond Plus Columns, supplied by PROTEINA Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/at+proteina+diamond+plus+columns/at+proteina+diamond+plus+columns/10__1016_slash_j__bej__2024__109428-79-10-10
Average 90 stars, based on 1 article reviews
at proteina diamond plus columns - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Cell Culture:Article Title: Overcoming the inconsistent cell culture performance caused by single-use bioreactors during scaling-up the manufacturing process for a therapeutic bispecific antibody Article Snippet: Single use technology has been widely used in modern biopharmaceutical process development and manufacturing.. However, there are concerns about the adverse effects of disposable materials on bioprocess, product quality and patient safety.. Recently, we observed slow cell growth, increased lactate accumulation, and decreased production titer during scaling up a bispecific antibody (BsAb) upstream process from 3 L to 500 L bioreactor. Purification:Article Title: Overcoming the inconsistent cell culture performance caused by single-use bioreactors during scaling-up the manufacturing process for a therapeutic bispecific antibody Article Snippet: Single use technology has been widely used in modern biopharmaceutical process development and manufacturing.. However, there are concerns about the adverse effects of disposable materials on bioprocess, product quality and patient safety.. Recently, we observed slow cell growth, increased lactate accumulation, and decreased production titer during scaling up a bispecific antibody (BsAb) upstream process from 3 L to 500 L bioreactor. Chromatography:Article Title: Overcoming the inconsistent cell culture performance caused by single-use bioreactors during scaling-up the manufacturing process for a therapeutic bispecific antibody Article Snippet: Single use technology has been widely used in modern biopharmaceutical process development and manufacturing.. However, there are concerns about the adverse effects of disposable materials on bioprocess, product quality and patient safety.. Recently, we observed slow cell growth, increased lactate accumulation, and decreased production titer during scaling up a bispecific antibody (BsAb) upstream process from 3 L to 500 L bioreactor. High Performance Liquid Chromatography:Article Title: Overcoming the inconsistent cell culture performance caused by single-use bioreactors during scaling-up the manufacturing process for a therapeutic bispecific antibody Article Snippet: Single use technology has been widely used in modern biopharmaceutical process development and manufacturing.. However, there are concerns about the adverse effects of disposable materials on bioprocess, product quality and patient safety.. Recently, we observed slow cell growth, increased lactate accumulation, and decreased production titer during scaling up a bispecific antibody (BsAb) upstream process from 3 L to 500 L bioreactor. |